Your browser doesn't support javascript.
loading
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Moore, Kathleen N; Secord, Angeles Alvarez; Geller, Melissa A; Miller, David Scott; Cloven, Noelle; Fleming, Gini F; Wahner Hendrickson, Andrea E; Azodi, Masoud; DiSilvestro, Paul; Oza, Amit M; Cristea, Mihaela; Berek, Jonathan S; Chan, John K; Rimel, Bobbie J; Matei, Daniela E; Li, Yong; Sun, Kaiming; Luptakova, Katarina; Matulonis, Ursula A; Monk, Bradley J.
Afiliação
  • Moore KN; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: kathleen-moore@ouhsc.edu.
  • Secord AA; Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Health System, Durham, NC, USA.
  • Geller MA; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Miller DS; Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Cloven N; Division of Gynecologic Oncology, Texas Oncology-Fort Worth, Fort Worth, TX, USA.
  • Fleming GF; Department of Medicine, The University of Chicago Medicine, Chicago, IL, USA.
  • Wahner Hendrickson AE; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Azodi M; Department of Obstetrics, Gynecology, and Reproductive Sciences, Smilow Cancer Hospital at Yale and Yale University, New Haven, CT, USA.
  • DiSilvestro P; Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA.
  • Oza AM; Division of Medical Oncology and Hematology, University Health Network and Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Cristea M; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.
  • Berek JS; Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford, CA, USA.
  • Chan JK; Division of Gynecologic Oncology, Sutter Health, San Francisco, CA, USA.
  • Rimel BJ; Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Matei DE; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Li Y; Division of Biostatistics, Tesaro, Waltham, MA, USA.
  • Sun K; Division of Translational Research & Development, Tesaro, Waltham, MA, USA.
  • Luptakova K; Division of Clinical Research, Tesaro, Waltham, MA, USA.
  • Matulonis UA; Division of Gynecologic Oncology, Harvard Medical School, Boston, MA, USA.
  • Monk BJ; Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St Joseph's Hospital, Phoenix, AZ, USA.
Lancet Oncol ; 20(5): 636-648, 2019 05.
Article em En | MEDLINE | ID: mdl-30948273
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Piperidinas / Neoplasias das Tubas Uterinas / Inibidores de Poli(ADP-Ribose) Polimerases / Carcinoma Epitelial do Ovário / Indazóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Piperidinas / Neoplasias das Tubas Uterinas / Inibidores de Poli(ADP-Ribose) Polimerases / Carcinoma Epitelial do Ovário / Indazóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article